semaglutide and osteoporosis Does Ozempic (semaglutide) increase the risk of osteoporosis? Worried About Bone Loss on

By Tyler M

In fact, research indicates that those using Ozempic can lose an average of 15% of their body weight within the first year of treatment

Observational reports and clinical experience suggest that patients achieving adequate weight loss on GLP-1 monotherapy do not require phentermine addition

The SELECT trial is the first study providing long-term data on the safety and efficacy of semaglutide 2.4 mg [110]

The drug now carries a warning for severe pancreatitis and severe kidney injuries

Further high-quality randomised controlled trials are needed to clarify whether probiotics can meaningfully reduce GLP-1-associated gastrointestinal side effects and whether specific strains or formulations are superior